Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-09-04 02:11:41 UTC |
---|
Updated at | 2022-09-04 02:11:41 UTC |
---|
NP-MRD ID | NP0186364 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | [(2s,3r,4r,5s)-5-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-6-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-3-yl]oxy}-3,4-dihydroxyoxolan-2-yl]methyl acetate |
---|
Description | Cissoside III belongs to the class of organic compounds known as flavonoid-3-o-glycosides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C3-position. It was first documented in 2022 (PMID: 36057789). Based on a literature review a significant number of articles have been published on Cissoside III (PMID: 36057448) (PMID: 36057421) (PMID: 36057440) (PMID: 36057753) (PMID: 36057616) (PMID: 36057549). |
---|
Structure | C[C@@H]1O[C@@H](OC2=CC=C3OC(C4=CC=C(O)C(O)=C4)=C(O[C@@H]4O[C@@H](COC(C)=O)[C@H](O)[C@H]4O)C(=O)C3=C2O)[C@H](O)[C@H](O)[C@H]1O InChI=1S/C28H30O16/c1-9-18(32)22(36)24(38)27(40-9)42-15-6-5-14-17(19(15)33)21(35)26(25(41-14)11-3-4-12(30)13(31)7-11)44-28-23(37)20(34)16(43-28)8-39-10(2)29/h3-7,9,16,18,20,22-24,27-28,30-34,36-38H,8H2,1-2H3/t9-,16-,18-,20-,22+,23+,24+,27-,28-/m0/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C28H30O16 |
---|
Average Mass | 622.5320 Da |
---|
Monoisotopic Mass | 622.15338 Da |
---|
IUPAC Name | [(2S,3R,4R,5S)-5-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-6-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4H-chromen-3-yl]oxy}-3,4-dihydroxyoxolan-2-yl]methyl acetate |
---|
Traditional Name | [(2S,3R,4R,5S)-5-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-6-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-3-yl]oxy}-3,4-dihydroxyoxolan-2-yl]methyl acetate |
---|
CAS Registry Number | Not Available |
---|
SMILES | C[C@@H]1O[C@@H](OC2=CC=C3OC(C4=CC=C(O)C(O)=C4)=C(O[C@@H]4O[C@@H](COC(C)=O)[C@H](O)[C@H]4O)C(=O)C3=C2O)[C@H](O)[C@H](O)[C@H]1O |
---|
InChI Identifier | InChI=1S/C28H30O16/c1-9-18(32)22(36)24(38)27(40-9)42-15-6-5-14-17(19(15)33)21(35)26(25(41-14)11-3-4-12(30)13(31)7-11)44-28-23(37)20(34)16(43-28)8-39-10(2)29/h3-7,9,16,18,20,22-24,27-28,30-34,36-38H,8H2,1-2H3/t9-,16-,18-,20-,22+,23+,24+,27-,28-/m0/s1 |
---|
InChI Key | FQWPUSFOXKIWJB-JZHHZRDPSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as flavonoid-3-o-glycosides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C3-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Flavonoids |
---|
Sub Class | Flavonoid glycosides |
---|
Direct Parent | Flavonoid-3-O-glycosides |
---|
Alternative Parents | |
---|
Substituents | - Flavonoid-3-o-glycoside
- Hydroxyflavonoid
- Flavone
- 5-hydroxyflavonoid
- 4'-hydroxyflavonoid
- 3'-hydroxyflavonoid
- Phenolic glycoside
- O-glycosyl compound
- Glycosyl compound
- Chromone
- 1-benzopyran
- Benzopyran
- Catechol
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Pyranone
- Phenol
- Benzenoid
- Pyran
- Oxane
- Monosaccharide
- Monocyclic benzene moiety
- Heteroaromatic compound
- Vinylogous acid
- Tetrahydrofuran
- Secondary alcohol
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Polyol
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Acetal
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Agarwal K, Saikia P, Podder I: Metabolic syndrome and Dyslipidemia in xanthelasma palpebrarum and associated risk-factors- a case-control study. J Cosmet Dermatol. 2022 Sep 3. doi: 10.1111/jocd.15353. [PubMed:36057448 ]
- Rashid N, Krakow EF, Yeh A, Oshima MU, Onstad L, Connelly-Smith L, Vo P, Mielcarek M, Lee SJ: Late effects of severe acute GVHD on quality of life, medical comorbidities and survival. Transplant Cell Ther. 2022 Aug 31. pii: S2666-6367(22)01594-9. doi: 10.1016/j.jtct.2022.08.027. [PubMed:36057421 ]
- Castellanos-Ortega A, Broch MJ, Palacios-Castaneda D, Gomez-Tello V, Valdivia M, Vicent C, Madrid I, Martinez N, Parraga MJ, Sancho E, Fuentes-Dura MDC, Sancerni-Beitia MD, Garcia-Ros R: Competency assessment of residents of Intensive Care Medicine through a simulation-based objective structured clinical evaluation (OSCE). A multicenter observational study. Med Intensiva (Engl Ed). 2022 Sep;46(9):491-500. doi: 10.1016/j.medine.2022.01.001. [PubMed:36057440 ]
- Ogawa A, Kojima F, Miyake Y, Yoshimura M, Ishijima N, Iyoda S, Sekine Y, Yamanaka Y, Yamamoto K: Regulation of constant cell elongation and Sfm pili synthesis in Escherichia coli via two active forms of FimZ orphan response regulator. Genes Cells. 2022 Nov;27(11):657-674. doi: 10.1111/gtc.12982. Epub 2022 Sep 18. [PubMed:36057789 ]
- Liu Q, Palmgren VAC, Danen EH, Le Devedec SE: Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research. Mol Biol Rep. 2022 Nov;49(11):10961-10973. doi: 10.1007/s11033-022-07802-6. Epub 2022 Sep 3. [PubMed:36057753 ]
- Ebenau JL, Visser D, Kroeze LA, van Leeuwenstijn MSSA, van Harten AC, Windhorst AD, Golla SVS, Boellaard R, Scheltens P, Barkhof F, van Berckel BNM, van der Flier WM: Longitudinal change in ATN biomarkers in cognitively normal individuals. Alzheimers Res Ther. 2022 Sep 3;14(1):124. doi: 10.1186/s13195-022-01069-6. [PubMed:36057616 ]
- Beogo I, Bationo NJ, Sia D, Collin S, Kinkumba Ramazani B, Letourneau AA, Ramde J, Gagnon MP, Tchouaket EN: COVID-19 pandemic or chaos time management: first-line worker shortage - a qualitative study in three Canadian Provinces. BMC Geriatr. 2022 Sep 3;22(1):727. doi: 10.1186/s12877-022-03419-3. [PubMed:36057549 ]
- Chakraborty S, Bhattacharjee S, Tiwari B, Jaishwal T, Singh SS, Mishra AK: Deciphering the mechanisms of zinc tolerance in the cyanobacterium Anabaena sphaerica and its zinc bioremediation potential. Environ Sci Pollut Res Int. 2023 Jan;30(4):9591-9608. doi: 10.1007/s11356-022-22388-z. Epub 2022 Sep 3. [PubMed:36057058 ]
- Chi Z, Ju S, Liu X, Sun F, Zhu Y: Graphene oxide supported sulfidated nano zero-valent iron (S-nZVI@GO) for antimony removal: The role of active oxygen species and reaction mechanism. Chemosphere. 2022 Dec;308(Pt 1):136253. doi: 10.1016/j.chemosphere.2022.136253. Epub 2022 Aug 31. [PubMed:36057347 ]
- Larsen MB, Hedelund M, Flander L, Andersen B: The impact of pre-notifications and reminders on participation in colorectal cancer screening - A randomised controlled trial. Prev Med. 2022 Nov;164:107229. doi: 10.1016/j.ypmed.2022.107229. Epub 2022 Aug 31. [PubMed:36057390 ]
- Hui Z, Chang M, Hu M: Sensitive analysis of pneumonia related small extracellular vesicles (sEVs) through Exo-III assisted catalytic DNA amplification. Anal Biochem. 2022 Nov 1;656:114875. doi: 10.1016/j.ab.2022.114875. Epub 2022 Aug 31. [PubMed:36057365 ]
- Cho SH, Lim KH: Conservative treatment of blunt traumatic right renal venous pseudoaneurysm: A case report. Int J Surg Case Rep. 2022 Sep;98:107572. doi: 10.1016/j.ijscr.2022.107572. Epub 2022 Aug 31. [PubMed:36057247 ]
- Wang Q, Zhang M, Li R, Jiang XT: Does marine environmental research meet the challenges of marine pollution induced by the COVID-19 pandemic? Comparison analysis before and during the pandemic based on bibliometrics. Mar Pollut Bull. 2022 Oct;183:114046. doi: 10.1016/j.marpolbul.2022.114046. Epub 2022 Aug 15. [PubMed:36057155 ]
- Alderuccio JP, Reis IM, Habermann TM, Link BK, Thieblemont C, Conconi A, Larson MC, Cascione L, Zhao W, Cerhan JR, Zucca E, Lossos IS: Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma. Am J Hematol. 2022 Dec;97(12):1529-1537. doi: 10.1002/ajh.26715. Epub 2022 Sep 19. [PubMed:36057138 ]
- Bello AA, Renai J, Hassan A, Akadiri SS, Itari AR: Synergy effects of ICT diffusion and foreign direct investment on inclusive growth in Sub-Saharan Africa. Environ Sci Pollut Res Int. 2023 Jan;30(4):9428-9444. doi: 10.1007/s11356-022-22689-3. Epub 2022 Sep 3. [PubMed:36057065 ]
- LOTUS database [Link]
|
---|